Agility Equity Partners announced the successful exit of its investment in Catalyst Clinical Research through the company’s sale to Worldwide Clinical Trials, a leading global contract research organization.

Agility Equity Partners announced its investment in TPI Efficiency, a Cleveland-based utility management platform.

Agility Equity Partners is proud to announce its participation in Incline Equity Partners’ first continuation vehicle (“CV”), supporting the rapid growth of Accredited Labs.

Tail End Capital Partners is excited to announce it is rebranding to Agility Equity Partners (“Agility Equity”), effective immediately.

Tail End and Rally have acquired a controlling stake in a leading distributor within the horticulture industry.

Tail End Capital (“Tail End”) completed a GP-led secondary investment into a CV managed by Kian Capital Partners.

Tail End Capital (“Tail End”) successfully exited its investment in Gelpac with its sale to ProAmpac

Tail End Capital Partners (“Tail End”) completed a GP-led secondary investment into a continuation fund vehicle managed by QHP Capital L.P. (“QHP”)

Tail End Capital Partners (“Tail End”) completed a GP-led secondary investment into an oversubscribed continuation vehicle (“CV”) managed by Frontenac.

Tail End Capital (“Tail End”) completed a GP-led secondary investment into a continuation vehicle managed by Stellex Capital Management.

Tail End Capital (“Tail End”) completed a GP-led secondary investment into a continuation vehicle managed by Persistence Capital Partners.

Tail End Capital ("Tail End") today announced that Justin Bertram has joined as a Partner.